Clinical Trials for BKM120

1 Open Trial

Trial TypeProtocol No. &
Open Date
A Phase III Randomized, Double Blind Placebo Controlled Study of BKM120 with Fulvestrant, in Postmenopausal Women with Hormone Receptor-Positive HER2-Negative Locally Advanced or Metastatic Breast Cancer Which Progressed On or After Aromatase Inhibitor Treatment

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.